ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.92563
-0.34%
Brent Oil
83.565
0.53%
Bitcoin
64,580.52
0.91%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) Noticias

VRDN Viridian Therapeutics Inc

15.40
0.00 (0.00%)
Pre Mercado
Última actualización: 05:07:32
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Viridian Therapeutics Inc VRDN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 15.40 05:07:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202407:00BWViridian Therapeutics Announces Inducement Grants Under..
29/4/202407:00BWViridian Therapeutics to Webcast First Quarter 2024..
04/4/202415:01BWViridian Therapeutics Announces Inducement Grants Under..
06/3/202415:01BWViridian Therapeutics Announces Inducement Grants Under..
05/3/202407:00BWViridian Therapeutics to Participate in the Leerink Partners..
28/2/202415:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202415:07EDGAR2Form 8-K - Current report
27/2/202415:01BWViridian Therapeutics Highlights Recent Progress and Reports..
16/2/202407:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
14/2/202419:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:01BWViridian Therapeutics Announces Inducement Grant Under..
24/1/202417:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202416:12EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202416:22EDGAR2Form 8-K - Current report
19/1/202415:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202421:00BWViridian Therapeutics Announces Pricing of Public Offering..
17/1/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202415:01BWViridian Therapeutics Announces Proposed Underwritten Public..
12/1/202415:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202407:08EDGAR2Form 8-K - Current report
08/1/202407:00BWViridian Therapeutics to Present Key 2024 Corporate..
04/1/202407:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
18/12/202310:45EDGAR2Form 144 - Report of proposed sale of securities
18/12/202307:15EDGAR2Form 8-K - Current report
18/12/202306:00BWViridian Therapeutics Announces Positive Clinical Data in..
12/12/202315:19EDGAR2Form 144 - Report of proposed sale of securities
08/12/202315:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/12/202315:22EDGAR2Form 144 - Report of proposed sale of securities
01/12/202315:04EDGAR2Form 144 - Report of proposed sale of securities
30/11/202315:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
21/11/202307:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
13/11/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
08/11/202307:00BWViridian Therapeutics to Participate in the Jefferies London..
03/11/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202307:00BWViridian Therapeutics Announces Encore Presentations at the..
01/11/202320:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202307:35EDGAR2Form 8-K - Current report
30/10/202307:30BWViridian Therapeutics Appoints New Chief Executive Officer,..

Su Consulta Reciente

NASDAQ
VRDN
Viridian Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados